DASATINIB NEWLINE PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
DASATINIB NEWLINE PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Pending
Register Number
86017
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jun 14, 2021
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number86017
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
DASATINIBActive
Quantity: 20 mg
Name: DASATINIB
ATC CLASSIFICATION (3)
L01E
L01EA
L01EA02